article thumbnail

Medicinal Cannabis – How far have we really come?

Cannabis Law Report

Natalie has worked with private hospitals and clinics in relation to medical malpractice claims, and assisted on cases involving medical devices product liability and clinical trials. Our seminar on Wednesday 6 March will look at the use of medicinal cannabis in more detail.

article thumbnail

Five Things to Know About Hemp-CBD in Pet Products

Canna Law Blog

That changed when I started looking into Hemp CBD pet products in preparing for a CLE put on by the Seminar Group. When it comes to CBD the, research is limited but a small clinical trial at Colorado State University found that CBD oil reduced seizures in epileptic dogs meaning that it may have similar effects as found in humans.

Pets 58
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The John Hopkins Center for Psychedelic and Consciousness Research Publishes Inaugural Edition Of Newsletter

Cannabis Law Report

Dr. Griffiths and Dr. Johnson will be speaking at Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks conference in Washington DC. Dr. Johnson will be presenting “Psychedelics and behavior change” at the Harvard/McLean Hospital’s Neuroscience Seminar Series.

Therapy 59
article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex. There haven’t been enough clinical trials and there never will be,” said Mr. Clarke, the cannabis seed collector. And with this group, finally, it seemed to be coming together. The Stanleys told me their wait-list peaked at 15,000 names.

CBD 40
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

upcoming seminars). It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis. 14) and general information or guidelines for practitioners ( n ?=?6). Three articles were audience polls about medicinal cannabis and three were sponsored content (e.g.